{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:08:25Z","timestamp":1793225305513,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s40264-016-0479-9","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T16:58:06Z","timestamp":1479833886000},"page":"121-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"40","author":[{"given":"Fatma","family":"Etwel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren H.","family":"Faught","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,22]]},"reference":[{"key":"479_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/CLEP.S16305","volume":"3","author":"O Stephansson","year":"2011","unstructured":"Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol. 2011;3:43\u201350.","journal-title":"Clin Epidemiol."},{"key":"479_CR2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajog.2005.02.100","volume":"193","author":"MM Werler","year":"2005","unstructured":"Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over the-counter medications during pregnancy. Am J Obstet Gynecol. 2005;193:771\u20137.","journal-title":"Am J Obstet Gynecol."},{"issue":"6","key":"479_CR3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaip.2013.07.008","volume":"1","author":"Q Li","year":"2013","unstructured":"Li Q, Mitchell AA, Werler MM, Yau WP, Hern\u00e1ndez-D\u00edaz S. Assessment of antihistamine use in early pregnancy and birth defects. J Allergy Clin Immunol Pract. 2013;1(6):666\u201374.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"9","key":"479_CR4","first-page":"695","volume":"35","author":"M Woolhouse","year":"2006","unstructured":"Woolhouse M. Complementary medicine for pregnancy complications. Aust Fam Physician. 2006;35(9):695.","journal-title":"Aust Fam Physician."},{"issue":"9","key":"479_CR5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1183\/09031936.93.05091137","volume":"5","author":"J Bousquet","year":"1992","unstructured":"Bousquet J, Godard P, Michel FB. Antihistamines in the treatment of asthma. Eur Respir J. 1992;5(9):1137\u201342.","journal-title":"Eur Respir J."},{"key":"479_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.ph.41.030179.000343","volume":"41","author":"AH Soll","year":"1979","unstructured":"Soll AH, Walsh JH. Regulation of gastric acid secretion. Annu Rev Physiol. 1979;41:35\u201353.","journal-title":"Annu Rev Physiol."},{"issue":"10","key":"479_CR7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/pds.3637","volume":"23","author":"TD Aldridge","year":"2014","unstructured":"Aldridge TD, Hartmann KE, Michels KA, Velez Edwards DR. First-trimester antihistamine exposure and risk of spontaneous abortion or preterm birth. Pharmacoepidemiol Drug Saf. 2014;23(10):1043\u201350.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"479_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00002018-200427060-00001","volume":"27","author":"KE Shields","year":"2004","unstructured":"Shields KE, Wiholm BE, Hostelley LS, Striano LF, Arena SR, Sharrar RG. Monitoring outcomes of pregnancy following drug exposure: a company-based pregnancy registry program. Drug Saf. 2004;27:353\u201367.","journal-title":"Drug Saf."},{"key":"479_CR9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-pharmtox-011613-135930","volume":"54","author":"F Etwel","year":"2014","unstructured":"Etwel F, Hutson JR, Madadi P, Gareri J, Koren G. Fetal and perinatal exposure to drugs and chemicals: novel biomarkers of risk. Annu Rev Pharmacol Toxicol. 2014;54:295\u2013315.","journal-title":"Annu Rev Pharmacol Toxicol."},{"issue":"3","key":"479_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2007-994110","volume":"14","author":"A Seto","year":"1997","unstructured":"Seto A, Einarson T, Koren G. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis. Am J Perinatol. 1997;14(3):119\u201324.","journal-title":"Am J Perinatol."},{"issue":"8","key":"479_CR11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1055\/s-0033-1358772","volume":"31","author":"JW Chin","year":"2014","unstructured":"Chin JW, Gregor S, Persaud N. Re-analysis of safety data supporting doxylamine use for nausea and vomiting of pregnancy. Am J Perinatol. 2014;31(8):701\u201310.","journal-title":"Am J Perinatol."},{"issue":"1","key":"479_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/tera.1420500105","volume":"50","author":"PM McKeigue","year":"1994","unstructured":"McKeigue PM, Lamm SH, Linn S, Kutcher JS. Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies. Teratology. 1994;50(1):27\u201337.","journal-title":"Teratology."},{"issue":"4","key":"479_CR13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.1981.03320040043030","volume":"246","author":"B MacMahon","year":"1981","unstructured":"MacMahon B. More on Bendectin. JAMA. 1981;246(4):371\u20132.","journal-title":"JAMA."},{"issue":"10","key":"479_CR14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/106002808802201021","volume":"22","author":"TR Einarson","year":"1988","unstructured":"Einarson TR, Leeder JS, Koren G. A method for meta-analysis of epidemiological studies. Drug Intell Clin Pharm. 1988;22(10):813\u201324.","journal-title":"Drug Intell Clin Pharm."},{"issue":"9","key":"479_CR15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2165\/00002018-200831090-00006","volume":"31","author":"EB Schwarz","year":"2008","unstructured":"Schwarz EB, Moretti ME, Nayak S, Koren G. Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta analysis. Drug Saf. 2008;31(9):775\u201388.","journal-title":"Drug Saf."},{"issue":"5","key":"479_CR16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/01443615.2014.896887","volume":"34","author":"F Etwel","year":"2014","unstructured":"Etwel F, Djokanovic N, Moretti ME, Boskovic R, Martinovic J, Koren G. The fetal safety of cetirizine: an observational cohort study and meta-analysis. J Obstet Gynaecol. 2014;34(5):392\u20139.","journal-title":"J Obstet Gynaecol."},{"issue":"9","key":"479_CR17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ptj\/89.9.873","volume":"89","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Reprint\u2014preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther. 2009;89(9):873\u201380.","journal-title":"Phys Ther."},{"issue":"3","key":"479_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/bdra.10012","volume":"67","author":"SA Rasmussen","year":"2003","unstructured":"Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA, National Birth Defects Prevention Study. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2003;67(3):193\u2013201.","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"issue":"3","key":"479_CR19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000342876","volume":"74","author":"D Neubourg De","year":"2012","unstructured":"De Neubourg D, van Duijnhoven NT, Nelen WL, D\u2019Hooghe TM. Dutch translation of the ICMART-WHO revised glossary on ART terminology. Gynecol Obstet Invest. 2012;74(3):233\u201348.","journal-title":"Gynecol Obstet Invest."},{"key":"479_CR20","unstructured":"Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http:\/\/www.cochrane-handbook.org ."},{"issue":"2","key":"479_CR21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455\u201363.","journal-title":"Biometrics."},{"issue":"9","key":"479_CR22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol."},{"key":"479_CR23","first-page":"775","volume":"191","author":"General Practitioner Research Group","year":"1963","unstructured":"General Practitioner Research Group. General practitioner clinical trials: drugs in pregnancy survey. Practitioner. 1963;191:775\u201380.","journal-title":"Practitioner"},{"key":"479_CR24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(63)91243-1","volume":"26","author":"G Mellin","year":"1963","unstructured":"Mellin G, Katzenstein M. Meclozine and fetal abnormalities. Lancet. 1963;26:222\u20133.","journal-title":"Lancet"},{"key":"479_CR25","first-page":"245","volume":"5","author":"CA Bunde","year":"1963","unstructured":"Bunde CA, Bowles DM. A technique for controlled survey of case records. Curr Ther Res Clin Exp. 1963;5:245\u20138.","journal-title":"Curr Ther Res Clin Exp."},{"issue":"4","key":"479_CR26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0002-9378(65)90515-6","volume":"93","author":"J Yerushalmy","year":"1965","unstructured":"Yerushalmy J, Milkovich L. Evaluation of the teratogenic effect of meclizine in man. Am J Obstet Gynecol. 1965;93(4):553\u201362.","journal-title":"Am J Obstet Gynecol."},{"issue":"1","key":"479_CR27","first-page":"35","volume":"7","author":"S Erez","year":"1971","unstructured":"Erez S, Schifrin BS, Dirim O. Double-blind evaluation of hydroxyzine as an antiemetic in pregnancy. J Reprod Med. 1971;7(1):35\u20137.","journal-title":"J Reprod Med."},{"key":"479_CR28","doi-asserted-by":"crossref","unstructured":"Milkovich L,vandenBerg BJ. An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol. 1976;125(2):244\u2013248.","DOI":"10.1016\/0002-9378(76)90601-3"},{"key":"479_CR29","doi-asserted-by":"crossref","unstructured":"Kullander S, K\u00e4ll\u00e9n B. A prospective study of drugs and pregnancy. II. Anti-emetic drugs. Acta Obstet Gynecol Scand. 1976;55(2):105\u201311.","DOI":"10.3109\/00016347609156795"},{"key":"479_CR30","volume-title":"Birth defects and drugs in pregnancy","author":"OP Heinonen","year":"1977","unstructured":"Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton: PSG Publishing; 1977."},{"key":"479_CR31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1479-828X.1977.tb02610.x","volume":"17","author":"NM Newman","year":"1977","unstructured":"Newman NM, Correy JF, Dudgeon GI. A survey of congenital abnormalities and drugs in a private practice. Aust N Z J Gynaecol. 1977;17:156\u20139.","journal-title":"Aust N Z J Gynaecol."},{"issue":"6111","key":"479_CR32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/bmj.1.6111.483","volume":"1","author":"S Shapiro","year":"1978","unstructured":"Shapiro S, Kaufman DW, Rosenberg L, Slone D, Monson RR, Siskind V, Heinonen OP. Meclizine in pregnancy in relation to congenital malformations. Br Med J. 1978;1(6111):483.","journal-title":"Br Med J."},{"issue":"1","key":"479_CR33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/tera.1420170109","volume":"17","author":"RW Smithells","year":"1978","unstructured":"Smithells RW, Sheppard S. Teratogenicity testing in humans: a method demonstrating safety of bendectin. Teratology. 1978;17(1):3\u2013135.","journal-title":"Teratology."},{"issue":"4","key":"479_CR34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jama.1981.03320040015021","volume":"246","author":"H Jick","year":"1981","unstructured":"Jick H, Holmes LB, Hunter JR, Madsen S, Stergachis A. First trimester drug use and congenital disorders. JAMA. 1981;246(4):343\u20136.","journal-title":"JAMA."},{"issue":"6284","key":"479_CR35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/bmj.283.6284.99","volume":"283","author":"DM Fleming","year":"1981","unstructured":"Fleming DM, Knox JDE, Crombie DL. Debendox in early pregnancy and fetal malformation. Br Med J (Clin Res Ed). 1981;283(6284):99\u2013101.","journal-title":"Br Med J (Clin Res Ed)."},{"issue":"8","key":"479_CR36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5694\/j.1326-5377.1981.tb135682.x","volume":"1","author":"GT Gibson","year":"1981","unstructured":"Gibson GT, Colley DP, McMichael AJ, Hartshorne JM. Congenital anomalies in relation to the use of doxylamine\/dicyclomine and other antenatal factors: an ongoing prospective study. Med J Aust. 1981;1(8):410\u20134.","journal-title":"Med J Aust."},{"issue":"1","key":"479_CR37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/tera.1420270109","volume":"27","author":"J Michaelis","year":"1983","unstructured":"Michaelis J, Michaelis H, Gl\u00fcck E, Koller S. Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations. Teratology. 1983;27(1):57\u201364.","journal-title":"Teratology."},{"issue":"4","key":"479_CR38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0890-6238(93)90028-6","volume":"7","author":"A Seto","year":"1993","unstructured":"Seto A, Einarson T, Koren G. Evaluation of brompheniramine safety in pregnancy. Reprod Toxicol. 1993;7(4):393\u20135.","journal-title":"Reprod Toxicol."},{"issue":"4","key":"479_CR39","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0091-6749(96)70122-7","volume":"98","author":"A Pastuszak","year":"1996","unstructured":"Pastuszak A, Schick B, D\u2019Alimonte D, Donnenfeld A, Koren G. The safety of astemizole in pregnancy. J Allergy Clin Immunol. 1996;98(4):748\u201350.","journal-title":"J Allergy Clin Immunol."},{"issue":"2","key":"479_CR40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1081-1206(10)63385-6","volume":"78","author":"A Einarson","year":"1997","unstructured":"Einarson A, Bailey B, Jung G, Spizzirri D, Baillie M, Koren G. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol. 1997;78(2):183\u20136.","journal-title":"Ann Allergy Asthma Immunol."},{"issue":"2","key":"479_CR41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1081-1206(10)63382-0","volume":"78","author":"M Schatz","year":"1997","unstructured":"Schatz M, Petitti D. Antihistamines and pregnancy. Ann Allergy Asthma Immunol. 1997;78(2):157\u20139.","journal-title":"Ann Allergy Asthma Immunol."},{"issue":"8","key":"479_CR42","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1471-0528.1998.tb10234.x","volume":"105","author":"LV Wilton","year":"1998","unstructured":"Wilton LV, Pearce GL, Martin RM, Mackay FJ, Mann RD. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol. 1998;105(8):882\u20139.","journal-title":"Br J Obstet Gynaecol."},{"issue":"5","key":"479_CR43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0091-6749(99)70074-6","volume":"104","author":"R Loebstein","year":"1999","unstructured":"Loebstein R, Lalkin A, Addis A, Costa A, Lalkin I, Bonati M, Koren G. Pregnancy outcome after gestational exposure to terfenadine: a multicenter, prospective controlled study. J Allergy Clin Immunol. 1999;104(5):953\u20136.","journal-title":"J Allergy Clin Immunol."},{"issue":"3","key":"479_CR44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/jmf.11.3.146.152","volume":"11","author":"B K\u00e4ll\u00e9n","year":"2002","unstructured":"K\u00e4ll\u00e9n B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med. 2002;11(3):146\u201352.","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"7","key":"479_CR45","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1023\/A:1024891618953","volume":"18","author":"B K\u00e4ll\u00e9n","year":"2003","unstructured":"K\u00e4ll\u00e9n B, Mottet I. Delivery outcome after the use of meclozine in early pregnancy. Eur J Epidemiol. 2003;18(7):665\u20139.","journal-title":"Eur J Epidemiol."},{"issue":"7","key":"479_CR46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.jp.7210986","volume":"23","author":"FA Bsat","year":"2003","unstructured":"Bsat FA, Hoffman DE, Seubert DE. Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy. J Perinatol. 2003;23(7):531\u20135.","journal-title":"J Perinatol."},{"issue":"6","key":"479_CR47","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1067\/mai.2003.1499","volume":"111","author":"O Diav-Citrin","year":"2003","unstructured":"Diav-Citrin O, Shechtman S, Aharonovich A, Moerman L, Arnon J, Wajnberg R, Ornoy A. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study. J Allergy Clin Immunol. 2003;111(6):1239\u201343.","journal-title":"J Allergy Clin Immunol."},{"issue":"3","key":"479_CR48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1067\/mai.2003.130","volume":"111","author":"ME Moretti","year":"2003","unstructured":"Moretti ME, Caprara D, Coutinho CJ, Bar-Oz B, Berkovitch M, Addis A, Jovanovski E, Sch\u00fcler-Faccini L, Koren G. Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study. J Allergy Clin Immunol. 2003;111(3):479\u201383.","journal-title":"J Allergy Clin Immunol."},{"key":"479_CR49","unstructured":"Paulus W, Schloemp S, Sterzik K, Stoz F. Pregnancy outcome after exposure to cetirizine\/levocetirizine in the first trimester-a prospective controlled study. Reprod Toxicol. 2004;19(2):258 [Abstract]."},{"issue":"8","key":"479_CR50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/bdra.20040","volume":"70","author":"R Boskovic","year":"2004","unstructured":"Boskovic R, Rudic N, Danieliewska-Nikiel B, Navioz Y, Koren G. Is lack of morning sickness teratogenic? A prospective controlled study. Birth Defects Res A Clin Mol Teratol. 2004;70(8):528\u201330.","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"issue":"1","key":"479_CR51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.reprotox.2008.05.053","volume":"26","author":"C Weber-Schoendorfer","year":"2008","unstructured":"Weber-Schoendorfer C, Schaefer C. The safety of cetirizine during pregnancy. A prospective observational cohort study. Reprod Toxicol. 2008;26(1):19\u201323.","journal-title":"Reprod Toxicol."},{"issue":"1","key":"479_CR52","first-page":"23","volume":"15","author":"L Ashkenazi-Hoffnung","year":"2013","unstructured":"Ashkenazi-Hoffnung L, Merlob P, Stahl B, Klinger G. Evaluation of the efficacy and safety of bi-daily combination therapy with pyridoxine and doxylamine for nausea and vomiting of pregnancy. Isr Med Assoc J. 2013;15(1):23\u20136.","journal-title":"Isr Med Assoc J."},{"issue":"8","key":"479_CR53","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0002-9378(82)90185-5","volume":"144","author":"B Eskenazi","year":"1982","unstructured":"Eskenazi B, Bracken MB. Bendectin (Debendox) as a risk factor for pyloric stenosis. Am J Obstet Gynecol. 1982;144(8):919\u201324.","journal-title":"Am J Obstet Gynecol."},{"issue":"2","key":"479_CR54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00404-004-0638-6","volume":"271","author":"AE Czeizel","year":"2005","unstructured":"Czeizel AE, Vargha P. A case-control study of congenital abnormality and dimenhydrinate usage during pregnancy. Arch Gynecol Obstet. 2005;271(2):113\u20138.","journal-title":"Arch Gynecol Obstet."},{"issue":"2","key":"479_CR55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/bdra.20513","volume":"85","author":"SM Gilboa","year":"2009","unstructured":"Gilboa SM, Strickland MJ, Olshan AF, Werler MM, Correa A, National Birth Defects Prevention Study. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol. 2009;85(2):137\u201350.","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"issue":"1\u20132","key":"479_CR56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/0748233708089003","volume":"24","author":"D Petik","year":"2008","unstructured":"Petik D, Acs N, B\u00e1nhidy F, Czeizel AE. A study of the potential teratogenic effect of large doses of promethazine used for a suicide attempt by 32 pregnant women. Toxicol Ind Health. 2008;24(1\u20132):87\u201396.","journal-title":"Toxicol Ind Health."},{"key":"479_CR57","doi-asserted-by":"crossref","unstructured":"Little BB, Snell LM, Breckenridge JD, Knoll KA, Klein VR, Gilstrap LC. Effects of T\u2019s and blues abuse on pregnancy outcome and infant health status. Am J Perinatol. 1990;7(4):359\u201362.","DOI":"10.1055\/s-2007-999523"},{"issue":"3","key":"479_CR58","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000457291","volume":"6","author":"IJ Chasnoff","year":"1983","unstructured":"Chasnoff IJ, Hatcher R, Burns WJ, Schnoll SH. Pentazocine and tripelennamine (\u2018T\u2019s and blue\u2019s\u2019): effects on the fetus and neonate. Dev Pharmacol Ther. 1983;6(3):162\u20139.","journal-title":"Dev Pharmacol Ther."},{"key":"479_CR59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.reprotox.2014.05.012","volume":"47","author":"G Koren","year":"2014","unstructured":"Koren G, Madjunkova S, Maltepe C. The protective effects of nausea and vomiting of pregnancy against adverse fetal outcome\u2013a systematic review. Reprod Toxicol. 2014;47:77\u201380.","journal-title":"Reprod Toxicol."},{"issue":"3","key":"479_CR60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1254\/jphs.FP0060862","volume":"102","author":"K Matsuyama","year":"2006","unstructured":"Matsuyama K, Ichikawa T, Nitta Y, Ikoma Y, Ishimura K, Horio S, Fukui H. Localized expression of histamine H1 receptors in syncytiotrophoblast cells of human placenta. J Pharmacol Sci. 2006;102(3):331\u20137.","journal-title":"J Pharmacol Sci."},{"key":"479_CR61","doi-asserted-by":"crossref","first-page":"136942","DOI":"10.1155\/2012\/136942","volume":"2012","author":"V Zohdi","year":"2012","unstructured":"Zohdi V, Sutherland MR, Lim K, Gubhaju L, Zimanyi MA, Black MJ. Low birth weight due to intrauterine growth restriction and\/or preterm birth: effects on nephron number and long-term renal health. Int J Nephrol. 2012;2012:136942.","journal-title":"Int J Nephrol."},{"issue":"5","key":"479_CR62","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1096-9926(200005)61:5<327::AID-TERA2>3.0.CO;2-H","volume":"61","author":"A Ornoy","year":"2000","unstructured":"Ornoy A, Mastroiacovo P. More on data from teratogen information systems (TIS). Teratology. 2000;61(5):327\u20138.","journal-title":"Teratology."},{"issue":"2","key":"479_CR63","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1067\/mob.2001.108073","volume":"184","author":"S Liu","year":"2001","unstructured":"Liu S, Wen SW, Demissie K, Marcoux S, Kramer MS. Maternal asthma and pregnancy outcomes: a retrospective cohort study. Am J Obstet Gynecol. 2001;184(2):90\u20136.","journal-title":"Am J Obstet Gynecol."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-016-0479-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-016-0479-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-016-0479-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T19:07:39Z","timestamp":1718910459000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-016-0479-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,22]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s40264-016-0479-9","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,22]]}}}